Literature DB >> 18006789

New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference.

Lee S Rosen1, Anton J Bilchik, Robert W Beart, Al B Benson, Kenneth J Chang, Carolyn C Compton, Axel Grothey, Daniel G Haller, Clifford Y Ko, Patrick M Lynch, Heidi Nelson, Michael J Stamos, Roderick R Turner, Christopher G Willett.   

Abstract

The 2007 Santa Monica Conference on Assessing and Treating Early-Stage Colon and Rectal Cancer, a multidisciplinary meeting of leaders in surgery, medical and radiation oncology, and pathology, was convened on January 12 to 13, 2007. The purpose of the meeting was to assess current data and issues in the field and to develop recommendations for advancing patient care and clinical research. Topics included pathologic assessment and staging, transanal versus laparoscopic versus open resection, adjuvant therapy, genetic testing and counseling, cooperative group strategies, and the use of biological therapies and novel agents. A review of the key issues discussed, as well as conclusions and recommendations considered significant to the field, is summarized below and presented at greater length in the individual manuscripts and accompanying discussion that comprise the full conference proceedings. Although the management of early-stage colon and rectal cancers remains a challenge for all of us, the development and use of new technologies and methods of assessment and treatment over the past several decades is yielding encouraging results. A variety of opportunities to further improve outcomes were addressed in this forum, including recommendations that specific protocols be adopted regarding surgical and pathologic dissection and reporting, particularly for stage II disease; the corollary need to increase active multidisciplinary collaboration; and the development of comprehensive consensus guidelines and recommendations to standardize care in early-stage colorectal cancer.

Entities:  

Mesh:

Year:  2007        PMID: 18006789     DOI: 10.1158/1078-0432.CCR-07-1629

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  5 in total

1.  Previstage GCC test for staging patients with colorectal cancer.

Authors:  Alex Mejia; Scott A Waldmana
Journal:  Expert Rev Mol Diagn       Date:  2008-09       Impact factor: 5.225

2.  Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer.

Authors:  Shuji Ogino; Gregory J Kirkner; Katsuhiko Nosho; Natsumi Irahara; Shoko Kure; Kaori Shima; Aditi Hazra; Andrew T Chan; Reiko Dehari; Edward L Giovannucci; Charles S Fuchs
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

3.  Clinical significance of pT sub-classification in surgical pathology of colorectal cancer.

Authors:  Marion J Pollheimer; Peter Kornprat; Verena S Pollheimer; Richard A Lindtner; Andrea Schlemmer; Peter Rehak; Cord Langner
Journal:  Int J Colorectal Dis       Date:  2009-10-09       Impact factor: 2.571

Review 4.  Quality matters: International standards for biobanking.

Authors:  Georges Dagher
Journal:  Cell Prolif       Date:  2022-06-16       Impact factor: 8.755

5.  Single-incision laparoscopic colectomy for cancer: short-term outcomes and comparative analysis.

Authors:  Rodrigo Pedraza; Ali Aminian; Javier Nieto; Chadi Faraj; T Bartley Pickron; Eric M Haas
Journal:  Minim Invasive Surg       Date:  2013-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.